Halozyme wins Dutch court order to halt Merck Keytruda in eight markets

Halozyme said on Wednesday that a Dutch patent court ruled in its favor against Merck, ordering the drugmaker to halt the manufacture and sale of injectable Keytruda in eight European markets. Here are some details